{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/SPRO/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T13:07:10.436Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":6809,"canonical_name":"Spero Therapeutics, Inc.","cik":"0001701108","uei":null,"lei":null,"duns":null,"ticker":"SPRO"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":28},"count":28,"timeline":[{"ts":"2026-09-10","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Spero Therapeutics, Inc. — 2026-09-10","url_slug":"/sec/cik-0001701108/effect/9999999995-26-002937","accession_number":"9999999995-26-002937","importance":30},{"ts":"2026-08-28","kind":"sec.filing","form_type":"8-K","title":"8-K — Spero Therapeutics, Inc. — 2026-08-28","url_slug":"/sec/cik-0001701108/8-k/0001193125-26-374788","accession_number":"0001193125-26-374788","importance":35},{"ts":"2026-08-28","kind":"sec.filing","form_type":"S-3","title":"S-3 — Spero Therapeutics, Inc. — 2026-08-28","url_slug":"/sec/cik-0001701108/s-3/0001193125-26-374702","accession_number":"0001193125-26-374702","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Spero Therapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001701108/10-q/0001193125-26-346795","accession_number":"0001193125-26-346795","importance":45},{"ts":"2026-08-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Spero Therapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001701108/8-k/0001193125-26-346855","accession_number":"0001193125-26-346855","importance":35},{"ts":"2026-08-06","kind":"sec.filing","form_type":"3","title":"3 — Spero Therapeutics, Inc. — 2026-08-06","url_slug":"/sec/cik-0001701108/3/0001807743-26-000005","accession_number":"0001807743-26-000005","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"4","title":"4 — Spero Therapeutics, Inc. — 2026-08-06","url_slug":"/sec/cik-0001701108/4/0001807743-26-000007","accession_number":"0001807743-26-000007","importance":30},{"ts":"2026-08-03","kind":"sec.insider.a","reporter":"Zack Debra","title":"Chief Medical Officer","shares":162311,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Spero Therapeutics, Inc. — 2026-07-14","url_slug":"/sec/cik-0001701108/8-k/0001193125-26-302473","accession_number":"0001193125-26-302473","importance":35},{"ts":"2026-06-25","kind":"sec.filing","form_type":"8-K","title":"8-K — Spero Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001701108/8-k/0001193125-26-283033","accession_number":"0001193125-26-283033","importance":35},{"ts":"2026-06-25","kind":"sec.filing","form_type":"4","title":"4 — Jackson Scott Thomas — 2026-06-25","url_slug":"/sec/cik-0001566617/4/0001193125-26-283202","accession_number":"0001193125-26-283202","importance":30},{"ts":"2026-06-25","kind":"sec.filing","form_type":"4","title":"4 — Spero Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001701108/4/0001193125-26-283238","accession_number":"0001193125-26-283238","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"S-8","title":"S-8 — Spero Therapeutics, Inc. — 2026-06-23","url_slug":"/sec/cik-0001701108/s-8/0001193125-26-279429","accession_number":"0001193125-26-279429","importance":30},{"ts":"2026-06-23","kind":"sec.insider.10000","reporter":"Deshpande Milind","title":null,"shares":10000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-23","kind":"sec.insider.10000","reporter":"Tregoning Kathleen","title":null,"shares":10000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-23","kind":"sec.insider.a","reporter":"THOMAS FRANK E","title":null,"shares":10000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-23","kind":"sec.insider.a","reporter":"Pottage John C Jr","title":null,"shares":10000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-23","kind":"sec.insider.a","reporter":"Deshpande Milind","title":null,"shares":10000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-23","kind":"sec.insider.a","reporter":"Jackson Scott Thomas","title":null,"shares":10000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-23","kind":"sec.insider.a","reporter":"VINK PATRICK V.J.J.","title":null,"shares":10000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-23","kind":"sec.insider.a","reporter":"Smith Cynthia","title":null,"shares":10000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-23","kind":"sec.insider.a","reporter":"Tregoning Kathleen","title":null,"shares":10000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-22","kind":"sec.filing","form_type":"8-K","title":"8-K — Spero Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001701108/8-k/0001193125-26-277506","accession_number":"0001193125-26-277506","importance":35},{"ts":"2026-05-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Spero Therapeutics, Inc. — 2026-05-13","url_slug":"/sec/cik-0001701108/10-q/0001193125-26-221591","accession_number":"0001193125-26-221591","importance":45},{"ts":"2026-05-13","kind":"sec.filing","form_type":"8-K","title":"8-K — Spero Therapeutics, Inc. — 2026-05-13","url_slug":"/sec/cik-0001701108/8-k/0001193125-26-221567","accession_number":"0001193125-26-221567","importance":35},{"ts":"2026-04-27","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Spero Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001701108/def-14a/0001193125-26-182201","accession_number":"0001193125-26-182201","importance":40},{"ts":"2026-04-27","kind":"sec.filing","form_type":"ARS","title":"ARS — Spero Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001701108/ars/0001193125-26-182287","accession_number":"0001193125-26-182287","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Spero Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001701108/defa14a/0001193125-26-182256","accession_number":"0001193125-26-182256","importance":30}]}